Concepedia

Elizabeth E. Evans

EE

Statistics

Publications

15

Citations

667

H-Index

13

Active since

2001

Affiliations

Vaccinex (United States)(Current)

University of Rochester

Cleveland Clinic Lerner College of Medicine

National Institute on Deafness and Other Communication Disorders

Children's Hospital of Philadelphia

Elizabeth E. Evans is an author at Vaccinex (United States) specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

2001–2022

15

Publications

15

SEMA4D compromises blood–brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease

Ernest Smith, Alan S. Jonason, Christine Reilly et al. · Neurobiology of Disease · 2014 · 112 citations · Full text

Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies

Elizabeth E. Evans, Alan S. Jonason, Sebold Torno et al. · Cancer Immunology Research · 2015 · 105 citations · Full text

A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk

Elad Katz, Sylvie Dubois-Marshall, Andrew H. Sims et al. · British Journal of Cancer · 2010 · 74 citations · Full text

Semaphorin4D Inhibition Improves Response to Immune-Checkpoint Blockade via Attenuation of MDSC Recruitment and Function

Paúl E. Clavijo, Jay Friedman, Yvette Robbins et al. · Cancer Immunology Research · 2018 · 59 citations · Full text

Pepinemab antibody blockade of SEMA4D in early Huntington’s disease: a randomized, placebo-controlled, phase 2 trial

Andrew Feigin, Elizabeth E. Evans, Terrence L. Fisher et al. · Nature Medicine · 2022 · 57 citations · Full text

1–5 of 15